REGN
Regeneron Pharmaceuticals
$807.67
+$2.66 (+0.33%)Oct 26, 2026
Key metrics
The numbers that frame REGN today
- Market cap
- $83.15B
- P/E (TTM)
- 20.0
- EV / FCF
- 22.2
- Gross margin
- 84.9%
- EV / Sales
- 5.4
- ROIC
- 15.1%
- Div yield
- 0.45%
- Debt / equity
- 0.1
- 52wk Low
- $573.06
- 52wk High
- $859.34
Growth
Revenue and earnings trend for REGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about REGN
Is Regeneron Pharmaceuticals a good buy?
Yes. Regeneron Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Regeneron Pharmaceuticals is selling at a low price.
What is the market capitalization of REGN?
Regeneron Pharmaceuticals's market capitalization is $83.15B.
What is the P/E (TTM) ratio for REGN stock?
Regeneron Pharmaceuticals's P/E (TTM) ratio is 20, based on trailing earnings.
What is the 52-week high for REGN stock?
The 52-week high for Regeneron Pharmaceuticals is $859.34. The current close of $807.67 is 6% below that high.
What is the 52-week low for REGN stock?
The 52-week low for Regeneron Pharmaceuticals is $573.06. The current close of $807.67 is 40.9% above that low.
Does REGN stock pay dividends?
Regeneron Pharmaceuticals pays a dividend. The latest dividend per share in the company data is $3.64, which implies a yield of 0.45% based on the current close.
What is the Debt / Equity ratio for REGN?
Regeneron Pharmaceuticals's Debt / Equity ratio is 0.09.